Provided by Tiger Trade Technology Pte. Ltd.

iRadimed

85.40
+0.10000.12%
Post-market: 85.400.00000.00%19:30 EDT
Volume:119.45K
Turnover:10.22M
Market Cap:1.09B
PE:47.71
High:86.27
Open:86.14
Low:84.53
Close:85.30
52wk High:107.90
52wk Low:70.80
Shares:12.79M
Float Shares:8.31M
Volume Ratio:0.73
T/O Rate:1.44%
Dividend:0.77
Dividend Rate:0.90%
EPS(TTM):1.79
EPS(LYR):1.75
ROE:23.52%
ROA:15.56%
PB:10.73
PE(LYR):48.80

Loading ...

Iradimed CFO Jack Glenn to Hold Investor Meetings at ROTH Healthcare Opportunities Conference

Reuters
·
Sep 23

IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

GlobeNewswire
·
Sep 23

iRadimed Initiated at Hold by Needham

Dow Jones
·
Sep 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD)

TIPRANKS
·
Sep 22

iRadimed initiated with a Hold at Needham

TIPRANKS
·
Sep 22

IRadimed Corporation : Needham Initiates Coverage with Hold Rating

THOMSON REUTERS
·
Sep 22

Needham Initiates IRadimed at Hold

MT Newswires Live
·
Sep 22

US Research Roundup-Boeing, Twilio, WP Carey

Reuters
·
Sep 22

Market Strategist Julie Biel: the AI Craze is Making These Quality Stocks More Affordable

Dow Jones
·
Sep 22

IRadimed Director Monty K. Allen Sells USD 122,604 of Common Shares

Reuters
·
Sep 09

iRadimed 2Q Revenue Rises as New Pump Launch Begins

Dow Jones
·
Aug 22

Integer Holdings Q2 Sales Fall 2.6%; KKR to Buy Company for $5.7 Billion

Reuters
·
Aug 03

IRadimed Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 01

IRadimed Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook, Reaffirms 2026 Guidance

MT Newswires Live
·
Jul 31

IRadimed Q2 Profit Rises on Record Monitor Bookings

Reuters
·
Jul 31

iRadimed Q2 Adj. EPS $0.46 Beats $0.42 Estimate, Sales $20.466M Beat $20.350M Estimate

Benzinga Earnings
·
Jul 31

GUIDANCE: (IRMD) IRadimed Expects 2026 Revenue Range $91M to $96M, vs. FactSet Est of $91.2M

MT Newswires Live
·
Jul 31

GUIDANCE: (IRMD) Iradimed Expects 2026 Adjusted EPS Range $2.09 to $2.24, vs. FactSet Est of $2.08

MT Newswires Live
·
Jul 31

IRadimed Q2 FY26 GAAP Diluted EPS Drops 9% to $0.41; Revenue Rises 0.5% to $20.5 Million

Reuters
·
Jul 31

IRadimed Corp: Continue to Gain Efficiencies, Which We Expect Will be Reflected in a Higher Gross Margin in Second Half of Year

THOMSON REUTERS
·
Jul 31